Chioma Ike Doctoral Project Proposal Defense, Friday, October 17, 2025 @ 3:00 pm Central Time
October 17, 2025 @ 3:00 pm - 4:00 pm
COMMITTEE CHAIR: Dr. Chloe Gaines
TITLE: INCREASING HUMAN PAPILLOMAVIRUS (HPV) VACCINATION RATES AMONG ADOLESCENTS IN THE PRIMARY CARE SETTING: A QUALITY IMPROVEMENT PROJECT
ABSTRACT: BACKGROUND: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, with an estimated new infection of 13 million occurring yearly. It is the most common viral infection of the reproductive system, and it is responsible for most cervical cancer cases worldwide. Many HPV related cancer deaths can be prevented with the simplest intervention of vaccination. The vaccine is most effective when administered before exposure to the HPV. Despite the HPV vaccine’s proven safety and efficacy, its uptake remains suboptimal. PURPOSE: This quality improvement project aims to train providers in a pediatric and family clinic on an effective communication strategy to increase the uptake of the HPV vaccination rate among adolescents aged 11-18 years. METHOD: A single-group, pre- and post-intervention design will be used to assess change in practice, measured as the number of HPV vaccines initiated in the medical records of adolescents in the three-month period post-intervention compared to the three-month period pre-intervention. The intervention involves training the providers on an effective communication strategy using the “Same-Way, Same-Day” approach. The primary outcome will be a change in the HPV vaccination initiation rate. Data will be collected by review of adolescents’ medical records by a designated “vaccine champion,” who will provide the data to the DNP student, de-identified to protect patients’ privacy and confidentiality. At each period, an estimated 300 adolescent patient records will be available for review, pre- and post-intervention. The primary outcome is a change in the HPV vaccination initiation rate, which will be assessed using the chi-square for independence of proportions. Additionally, to allow for exploration of subgroup differences in HPV vaccine initiation, patients’ demographics will be collected.
Location Online:
Zoom Link:
https://pvpanther.zoom.us/j/99591713347?pwd=TZmTVzGpH55VUFBpSvJ31HmVCCrbHJ.1
Meeting ID: 995 9171 3347
Passcode: 7 216600
